CD4 and infection: In addition to its modulatory effects on CD4+ T cells [9,10], VitD has been shown to decrease the activation and maturation profile of dendritic cells (DCs) [11–13]; therefore, it could reduce the ability of these cells to transfer HIV-1 viral particles to CD4+ T cells, contributing to reducing the viral spread that usually occurs during the initial stages of infection [14].